Virtual Screening for Potential Inhibitors of CTX-M-15 Protein of Klebsiella pneumoniae

Brisse S, Grimont F, Grimont PAD (2006) The genus Klebsiella. Prokaryotes 6:159–196 Podschun R, Ullmann U (1998) Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11(4):589–603 Dhingra KR (2008) A case of complicated urinary tract infection: Klebsiella pneumoniae emphysematous cystitis presenting as abdominal pain in the emergency department. West J Emerg Med 9(3):171–173 Vieira AT, Rocha VM, Tavares L, Garcia CC, Teixeira MM, Oliveira SC et al (2016) Control of Klebsiella pneumoniae pulmonary infection and immunomodulation by oral treatment with the commensal probiotic Bifidobacterium longum 51A. Microbes Infect 18(3):180–189 Wei YQ, Bi DX, Wei DQ et al (2016) Prediction of type II toxin–antitoxin loci in Klebsiella pneumoniae genome sequences. Interdiscip Sci Comput Life Sci 8:143. doi:10.1007/s12539-015-0135-6 Bonnet R (2004) Growing group of extended-spectrum b-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48:1–14 Coque TM, Baquero F, Canton R (2008) Increasing prevalence of ESBL producing Enterobacteriaceae in Europe. Euro Surveill 13(47):pii_19044. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_19044 Hawkey PM, Jones AM (2009) The changing epidemiology of resistance. J Antimicrob Chemother 6:i3–i10 Bethal CR, Taracila M, Shyr T, Thomson JM, Distler AM et al (2011) Exploring the inhibition of CTX-M-9 by b-lactamase inhibitors and carbapenems. Antimicrob Agents Chemother 55:3465–3475 Karim A, Poirel L, Nagarajan S, Nordmann P (2001) Plasmid mediated extended-spectrum b-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett 201:237–241 Bush K (2010) Bench-to-bedside review: the role of b-lactamases in antibioticresistant Gram-negative infections. Crit Care 14:224 Faheem M, Rehman MT, Danishuddin M, Khan AU (2013) Biochemical characterization of CTX-M-15 from enterobacter cloacae and designing a novel non-b-lactam-b-lactamase inhibitor. PLoS One 8(2):e56926. doi:10.1371/journal.pone.0056926 Akta Z, Kayacana Z, Onculb O (2012) In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae. Int J Antimicrob Agents 39:86–89 van Duin D, Bonomo RA (2016) Ceftazidime/Avibactam and Ceftolozane/Tazobactam: second-generation β-lactam/β-lactamase Inhibitor combinations. Clin Infect Dis 63(2):234–241. doi:10.1093/cid/ciw243 Farhadi T, Ranjbar MM (2017) Designing and modeling of complex DNA vaccine based on MOMP of Chlamydia trachomatis: an in silico approach. Netw Model Anal Health Inf Bioinf 6(1). doi:10.1007/s13721-016-0142-5 Farhadi T, Ovchinnikov RS, Ranjbar MM (2016) In silico designing of some agonists of toll-like receptor 5 as a novel vaccine adjuvant candidates. Netw Model Anal Health Inform Bioinforma 5(31). doi:10.1007/s13721-016-0138-1 Farhadi T, Nezafat N, Ghasemi Y, Karimi Z, Hemmati S, Erfani N (2015) Designing of complex multi-epitope peptide vaccine based on Omps of Klebsiella pneumoniae: an in silico approach. Int J Pept Res Ther 21(3):325–341 Farhadi T, Nezafat N, Ghasemi Y (2015) In silico phylogenetic analysis of Vibrio cholera isolates based on three housekeeping genes. Int J Comput Biol Drug Des 8(1):62–74 Singh N, Sudandiradoss C, Abraham J (2016) Screening of furanone in Cucurbita melo and evaluation of its bioactive potential using in silico studies. Interdiscip Sci Comput Life Sci 8:395. doi:10.1007/s12539-016-0161-z Padhi S, Das D, Panja S et al (2016) Molecular characterization and antimicrobial activity of an Endolichenic fungus, Aspergillus sp. isolated from Parmeliacaperata of similipal biosphere reserve, India. Interdiscip Sci Comput Life Sci. doi:10.1007/s12539-016-0146-y Vijayalakshmi P, Nisha J, Rajalakshmi M (2014) Virtual screening of potential inhibitor against FtsZ protein from Staphylococcus aureus. Interdiscip Sci Comput Life Sci 6:331–339. doi:10.1007/s12539-012-0229-3 Jorgensen WL (2004) The many roles of computation in drug discovery. Science 303:1813–1818 Clark DE (2008) What has virtual screening ever done for drug discovery? Expert opin drug dis 3:841–851 Vyas V, Jain A, Jain A, Gupta A (2008) Virtual screening: a fast tool for drug design. Sci Pharm 76:333–360. doi:10.3797/scipharm.0803-03 Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3–26 Ohtsuki S, Uchida Y, Kubo Y, Terasaki T (2011) Quantitative targeted absolute proteomics-based ADME research as a new path to drug discovery and development: methodology, advantages, strategy and prospects. J Pharm Sci 100:3547–3559 Forli S (2015) Charting a path to success in virtual screening. Molecules 20(10):18732–18758 Wolf LK (2009) New software and websites for the chemical enterprise. Chem Eng News 87:31 Irwin JJ, Brian K, Shoichet BK (2005) ZINC—a free database of commercially available compounds for virtual screening. J Chem Inf Model 45(1):177–182 Rose PW, Prlic A, Altunkaya A, Bi C, Bradley AR, Christie CH et al (2017) The RCSB protein data bank: integrative view of protein, gene and 3D structural information. Nucleic Acids Res 45:D271–D281 Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC et al (2004) UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605–1612 Gasteiger J, Marsili M (1980) Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges. Tetrahedron 36:3219–3228 Roy A, Yang J, Zhang Y (2012) COFACTOR: an accurate comparative algorithm for structure-based protein function annotation. Nucleic Acids Res 40:W471–W477 Yang J, Roy A, Zhang Y (2013) Protein-ligand binding site recognition using complementary binding-specific substructure comparison and sequence profile alignment. Bioinformatics 29:2588–2595 Leach AR, Shoichet BK, Peishoff CE (2006) Prediction of protein-ligand interactions docking and scoring: successes and gaps. J Med Chem 49:5851–5855 Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK (2004) Glide: a new approach for rapid, accurate docking and scoring: method and assessment of docking accuracy. J Med Chem 47:1739–1749 Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461 Kabsch W (1978) A discussion of the solution for the best rotation to relate two sets of vectors. Acta Cryst A 34:827–828 Zhang Y, Skolnick J (2004) Template-based modeling and free modeling by I-TASSER in CASP7. Proc Natl Acad Sci USA 101:7594–7599 Podlogar BL, Muegge I, Brice LJ (2001) Computational methods to estimate drug development parameters. Curr Opin Drug Discov Dev 4:102–109 Muegge I, Heald SL, Brittelli D (2001) Simple selection criteria for drug-like chemical matter. J Med Chem 44:1841–1846 Kumar S, Jena L, Mohod K, Daf S, Varma AK (2014) Virtual screening for potential inhibitors of high-risk human papillomavirus 16 E6 protein. Interdiscip Sci Comput Life Sci. doi:10.1007/s12539-015-0008-z Su AI, Lorber DM, Weston GS, Baase WA, Matthews BW, Shoichet BK (2001) Docking molecules by families to increase the diversity of hits in database screens: computational strategy and experimental evaluation. Proteins Struct Funct Bioinform 42:279–293 Eyal E, Gerzon S, Potapov V, Edelman M, Sobolev V (2005) The limit of accuracy of protein modeling: influence of crystal packing on protein structure. J Mol Biol 351:431–442